EcoDrugPlus

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSHBUG00000011490
Gene Symbol: LOC102294828
3 Cross references
202 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSHBUG00000002327
Gene Symbol: LOC102313933
3 Cross references
191 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSHBUG00000001834
Gene Symbol: LOC102308546
3 Cross references
174 Possible Orthologues:

Alpha-Synuclein-Like

Ensembl ID : ENSHBUG00000018523
Gene Symbol: LOC102301256
2 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSHBUG00000012882
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSHBUG00000013659
Gene Symbol: AOC2
1 Cross references
403 Possible Orthologues:

Amyloid Beta A4 Protein-Like

Ensembl ID : ENSHBUG00000023034
Gene Symbol: LOC102290887
3 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSHBUG00000007800
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSHBUG00000002755
Gene Symbol: AR
3 Cross references
206 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSHBUG00000021091
Gene Symbol: AR
4 Cross references
212 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSHBUG00000015996
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:

Apelin Receptor A-Like

Ensembl ID : ENSHBUG00000015466
Gene Symbol: LOC102311991
3 Cross references
171 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).